{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T01:31:21Z","timestamp":1768786281381,"version":"3.49.0"},"reference-count":44,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2010,1,1]],"date-time":"2010-01-01T00:00:00Z","timestamp":1262304000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,1,1]],"date-time":"2010-01-01T00:00:00Z","timestamp":1262304000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","metabolismjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Metabolism"],"published-print":{"date-parts":[[2010,1]]},"DOI":"10.1016\/j.metabol.2009.06.019","type":"journal-article","created":{"date-parts":[[2009,8,28]],"date-time":"2009-08-28T05:27:06Z","timestamp":1251437226000},"page":"7-13","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["The midregional portion of proadrenomedullin is an independent predictor of left ventricular mass index in hypertension"],"prefix":"10.1016","volume":"59","author":[{"given":"Sanjay S.","family":"Bhandari","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joan E.","family":"Davies","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joachim","family":"Struck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leong L.","family":"Ng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.metabol.2009.06.019_bib1","doi-asserted-by":"crossref","first-page":"75","DOI":"10.3109\/08037059209077497","article-title":"Pathologic hypertrophy with fibrosis: the structural basis for myocardial failure","volume":"1","author":"Weber","year":"1992","journal-title":"Blood Press"},{"key":"10.1016\/j.metabol.2009.06.019_bib2","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1161\/01.HYP.23.6.869","article-title":"Structural remodeling in hypertensive heart disease and the role of hormones","volume":"23","author":"Weber","year":"1994","journal-title":"Hypertension"},{"key":"10.1016\/j.metabol.2009.06.019_bib3","first-page":"117","article-title":"Left ventricular hypertrophy and geometric remodeling in hypertension: stimuli, functional consequences and prognostic implications","volume":"12","author":"Devereux","year":"1994","journal-title":"J Hypertens Suppl"},{"key":"10.1016\/j.metabol.2009.06.019_bib4","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1001\/jama.1996.03530430051039","article-title":"Reversal of left ventricular hypertrophy in essential hypertension. A meta-analysis of randomized double-blind studies","volume":"275","author":"Schmieder","year":"1996","journal-title":"JAMA"},{"key":"10.1016\/j.metabol.2009.06.019_bib5","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1161\/01.CIR.88.4.1444","article-title":"Role of preclinical cardiovascular disease in the evolution from risk factor exposure to development of morbid events","volume":"88","author":"Devereux","year":"1993","journal-title":"Circulation"},{"key":"10.1016\/j.metabol.2009.06.019_bib6","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1056\/NEJM199005313222203","article-title":"Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study","volume":"322","author":"Levy","year":"1990","journal-title":"N Engl J Med"},{"key":"10.1016\/j.metabol.2009.06.019_bib7","doi-asserted-by":"crossref","first-page":"7","DOI":"10.7326\/0003-4819-108-1-7","article-title":"Echocardiographically detected left ventricular hypertrophy: prevalence and risk factors. The Framingham Heart Study","volume":"108","author":"Levy","year":"1988","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.metabol.2009.06.019_bib8","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1038\/ajh.2008.2","article-title":"Regression of echocardiographic left ventricular hypertrophy after 2 years of therapy reduces cardiovascular risk in patients with essential hypertension","volume":"21","author":"Pierdomenico","year":"2008","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.metabol.2009.06.019_bib9","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1161\/01.HYP.27.2.251","article-title":"Time-voltage area of the QRS for the identification of left ventricular hypertrophy","volume":"27","author":"Okin","year":"1996","journal-title":"Hypertension"},{"key":"10.1016\/j.metabol.2009.06.019_bib10","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1097\/01.hjh.0000239305.01496.ca","article-title":"Left ventricular hypertrophy and cardiovascular risk stratification: impact and cost-effectiveness of echocardiography in recently diagnosed essential hypertensives","volume":"24","author":"Cuspidi","year":"2006","journal-title":"J Hypertens"},{"key":"10.1016\/j.metabol.2009.06.019_bib11","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0140-6736(97)03034-1","article-title":"Biochemical detection of left-ventricular systolic dysfunction","volume":"351","author":"McDonagh","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.metabol.2009.06.019_bib12","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1161\/01.HYP.28.6.988","article-title":"Superiority of brain natriuretic peptide as a hormonal marker of ventricular systolic and diastolic dysfunction and ventricular hypertrophy","volume":"28","author":"Yamamoto","year":"1996","journal-title":"Hypertension"},{"key":"10.1016\/j.metabol.2009.06.019_bib13","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1161\/01.CIR.93.11.1963","article-title":"Plasma brain natriuretic peptide as an indicator of left ventricular systolic function and long-term survival after acute myocardial infarction. Comparison with plasma atrial natriuretic peptide and N-terminal proatrial natriuretic peptide","volume":"93","author":"Omland","year":"1996","journal-title":"Circulation"},{"key":"10.1016\/j.metabol.2009.06.019_bib14","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/0002-9343(92)90011-Y","article-title":"Brain natriuretic peptide as a cardiac hormone in essential hypertension","volume":"92","author":"Kohno","year":"1992","journal-title":"Am J Med"},{"key":"10.1016\/j.metabol.2009.06.019_bib15","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1111\/j.1440-1681.1997.tb02729.x","article-title":"Plasma concentration of brain natriuretic peptide is related to diastolic function in hypertension","volume":"24","author":"Cheung","year":"1997","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"10.1016\/j.metabol.2009.06.019_bib16","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1161\/01.HYP.28.1.22","article-title":"Relationship between left ventricular geometry and natriuretic peptide levels in essential hypertension","volume":"28","author":"Nishikimi","year":"1996","journal-title":"Hypertension"},{"key":"10.1016\/j.metabol.2009.06.019_bib17","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.acvd.2008.04.007","article-title":"N-terminal pro-brain natriuretic peptide\u2014a promising biomarker for the diagnosis of left ventricular hypertrophy in hypertensive women","volume":"101","author":"Mouly-Bertin","year":"2008","journal-title":"Arch Cardiovasc Dis"},{"key":"10.1016\/j.metabol.2009.06.019_bib18","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1016\/j.amjhyper.2003.07.024","article-title":"The limited value of plasma B-type natriuretic peptide for screening for left ventricular hypertrophy among hypertensive patients","volume":"16","author":"Nakamura","year":"2003","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.metabol.2009.06.019_bib19","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1016\/S0195-668X(03)00476-7","article-title":"Clinical applications of B-type natriuretic peptide (BNP) testing","volume":"24","author":"Cowie","year":"2003","journal-title":"Eur Heart J"},{"key":"10.1016\/j.metabol.2009.06.019_bib20","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1006\/bbrc.1993.1451","article-title":"Adrenomedullin: a novel hypotensive peptide isolated from human pheochromocytoma","volume":"192","author":"Kitamura","year":"1993","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.metabol.2009.06.019_bib21","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/0014-5793(94)80106-1","article-title":"Distribution and characterization of immunoreactive adrenomedullin in human tissue and plasma","volume":"338","author":"Ichiki","year":"1994","journal-title":"FEBS Lett"},{"key":"10.1016\/j.metabol.2009.06.019_bib22","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1006\/bbrc.1994.1827","article-title":"Endothelial cells actively synthesize and secrete adrenomedullin","volume":"201","author":"Sugo","year":"1994","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.metabol.2009.06.019_bib23","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1006\/bbrc.1993.1881","article-title":"Cloning and characterization of cDNA encoding a precursor for human adrenomedullin","volume":"194","author":"Kitamura","year":"1993","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.metabol.2009.06.019_bib24","first-page":"95","article-title":"Circulating adrenomedullin does not regulate systemic blood pressure but increases plasma prolactin after intravenous infusion in humans: a pharmacokinetic study","volume":"82","author":"Meeran","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.metabol.2009.06.019_bib25","first-page":"138","article-title":"Adrenomedullin, a multifunctional regulatory peptide","volume":"21","author":"Hinson","year":"2000","journal-title":"Endocr Rev"},{"key":"10.1016\/j.metabol.2009.06.019_bib26","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1161\/01.CIR.95.5.1214","article-title":"Potent and long-lasting vasodilatory effects of adrenomedullin in humans. Comparisons between normal subjects and patients with chronic heart failure","volume":"95","author":"Nakamura","year":"1997","journal-title":"Circulation"},{"key":"10.1016\/j.metabol.2009.06.019_bib27","doi-asserted-by":"crossref","first-page":"178","DOI":"10.3181\/00379727-211-43959","article-title":"Renal effects of adrenomedullin in the rat","volume":"211","author":"Vari","year":"1996","journal-title":"Proc Soc Exp Biol Med"},{"key":"10.1016\/j.metabol.2009.06.019_bib28","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1038\/sj.bjp.0701034","article-title":"Direct cardiac and vascular actions of adrenomedullin in conscious sheep","volume":"120","author":"Parkes","year":"1997","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.metabol.2009.06.019_bib29","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/0014-5793(94)80474-5","article-title":"Immunoreactive adrenomedullin in human plasma","volume":"341","author":"Kitamura","year":"1994","journal-title":"FEBS Lett"},{"key":"10.1016\/j.metabol.2009.06.019_bib30","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1016\/j.jacc.2006.12.038","article-title":"Prognostic value of midregional pro-adrenomedullin in patients with acute myocardial infarction: the LAMP (Leicester Acute Myocardial Infarction Peptide) study","volume":"49","author":"Khan","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.metabol.2009.06.019_bib31","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.cardfail.2006.09.004","article-title":"Comparative evaluation of B-type natriuretic peptide, mid-regional pro\u2013A-type natriuretic peptide, mid-regional pro-adrenomedullin, and Copeptin to predict 1-year mortality in patients with acute destabilized heart failure","volume":"13","author":"Gegenhuber","year":"2007","journal-title":"J Card Fail"},{"key":"10.1016\/j.metabol.2009.06.019_bib32","doi-asserted-by":"crossref","first-page":"2749","DOI":"10.1681\/ASN.2007020199","article-title":"Evaluation of the modification of diet in renal disease study equation in a large diverse population","volume":"18","author":"Stevens","year":"2007","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.metabol.2009.06.019_bib33","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/0002-8703(49)90562-1","article-title":"The ventricular complex in left ventricular hypertrophy as obtained by unipolar precordial and limb leads","volume":"37","author":"Sokolow","year":"1949","journal-title":"Am Heart J"},{"key":"10.1016\/j.metabol.2009.06.019_bib34","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/S0894-7317(89)80014-8","article-title":"Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms","volume":"2","author":"Schiller","year":"1989","journal-title":"J Am Soc Echocardiogr"},{"key":"10.1016\/j.metabol.2009.06.019_bib35","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1093\/eurheartj\/14.suppl_D.8","article-title":"Methods for detection of left ventricular hypertrophy: application to hypertensive heart disease","volume":"14","author":"Devereux","year":"1993","journal-title":"Eur Heart J"},{"key":"10.1016\/j.metabol.2009.06.019_bib36","first-page":"151","article-title":"Guidelines for the management of hypertension","volume":"17","author":"Guidelines Subcommittee World Health Organization\/International Society of Hypertension (WHO\/ISH)","year":"1999","journal-title":"J Hypertens"},{"key":"10.1016\/j.metabol.2009.06.019_bib37","doi-asserted-by":"crossref","first-page":"2913","DOI":"10.1161\/01.CIR.0000041661.63285.AE","article-title":"N-terminal pro\u2013B-type natriuretic peptide and long-term mortality in acute coronary syndromes","volume":"106","author":"Omland","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.metabol.2009.06.019_bib38","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1373\/clinchem.2005.051110","article-title":"Measurement of midregional proadrenomedullin in plasma with an immunoluminometric assay","volume":"51","author":"Morgenthaler","year":"2005","journal-title":"Clin Chem"},{"key":"10.1016\/j.metabol.2009.06.019_bib39","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1016\/S0735-1097(02)02059-4","article-title":"Plasma brain natriuretic peptide concentration: impact of age and gender","volume":"40","author":"Redfield","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.metabol.2009.06.019_bib40","series-title":"Hypertension: pathophysiology, diagnosis and management","first-page":"409","article-title":"Hypertensive cardiac hypertrophy: patho-physiologic and clinical characteristics","author":"Devereux","year":"1995"},{"key":"10.1016\/j.metabol.2009.06.019_bib41","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1161\/01.HYP.30.3.741","article-title":"Plasma adrenomedullin concentrations and cardiac and arterial hypertrophy in hypertension","volume":"30","author":"Sumimoto","year":"1997","journal-title":"Hypertension"},{"key":"10.1016\/j.metabol.2009.06.019_bib42","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1152\/ajpheart.00107.2006","article-title":"Lack of activation of molecular forms of the BNP system in human grade 1 hypertension and relationship to cardiac hypertrophy","volume":"291","author":"Belluardo","year":"2006","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.metabol.2009.06.019_bib43","doi-asserted-by":"crossref","first-page":"2370","DOI":"10.1172\/JCI118680","article-title":"Cardiac secretion of adrenomedullin in human heart failure","volume":"97","author":"Jougasaki","year":"1996","journal-title":"J Clin Invest"},{"key":"10.1016\/j.metabol.2009.06.019_bib44","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1161\/01.CIR.92.3.286","article-title":"Elevation of circulating and ventricular adrenomedullin in human congestive heart failure","volume":"92","author":"Jougasaki","year":"1995","journal-title":"Circulation"}],"container-title":["Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049509002637?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049509002637?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T03:38:37Z","timestamp":1758425917000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0026049509002637"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,1]]},"references-count":44,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,1]]}},"alternative-id":["S0026049509002637"],"URL":"https:\/\/doi.org\/10.1016\/j.metabol.2009.06.019","relation":{},"ISSN":["0026-0495"],"issn-type":[{"value":"0026-0495","type":"print"}],"subject":[],"published":{"date-parts":[[2010,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The midregional portion of proadrenomedullin is an independent predictor of left ventricular mass index in hypertension","name":"articletitle","label":"Article Title"},{"value":"Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.metabol.2009.06.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}